Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma

The lack of sensitive and specific biomarkers hinders pathological diagnosis and prognosis for hepatocellular carcinoma (HCC). Since glutaminolysis plays a crucial role in carcinogenesis and progression, we sought to determine if the expression of kidney-type and liver-type glutaminases (GLS1 and GL...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Yu, Decai, Shi, Xianbiao, Meng, Gang, Chen, Jun, Yan, Chen, Jiang, Yong, Wei, Jiwu, Ding, Yitao
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2015
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4480704/
https://ncbi.nlm.nih.gov/pubmed/25844758
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items